AOArnold Ou

Arnold Ou

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Arnold Ou has a total of 54 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    CDK4/6 inhibition induces a senescence-associated secretory phenotype via delayed NF-κB activation

    by Joanna Lan-Hing Yeung, Justin Rendleman, Lauren Anderson Westcott, Arnold Ou, Matthew Pressler, Nicole Pagane, Irene Duba, Ria Hosuru, Bat-Ider Tumenbayar, Viviana I Risca

    Cellular senescence consists of regulated phenotypes associated with permanent exit from the cell cycle in response to stressors such as genomic instability. The consequences of senescence go beyond individual cells because of the senescence-associated secretory phenotype (SASP), which can induce inflammation in neighboring cells. Some cancers respond to CDK4/6 inhibitors (CDK4/6i) with a senescence-like phenotype in the absence of extensive DNA damage. We asked how the SASP and the transcriptional regulatory profile triggered by CDK4/6i-driven arrest compare with the canonical NF-κB–regulated SASP triggered by DNA damage. We profiled the dynamics of transcriptional regulation in response to the CDK4/6i, palbociclib, and the DNA-damaging agent, doxorubicin. We found that up-regulation of NF-κB–driven SASP genes was shared across both drugs, although delayed in CDK4/6i, coinciding with slower enhancer activation and epigenetic changes. ATM/ATR inhibition did not affect CDK4/6i-induced NF-κB nuclear localization, suggesting an alternative upstream activator. Inhibiting NF-κB suppressed the expression of SASP genes without reversing stable arrest, pointing to SASP manipulation as a potential therapeutic strategy and providing insights into controversies regarding cell cycle arrest–driven SASP.

  • Open Access

    CAD-C: An engineered nuclease enables repair-free in situ proximity ligation and nucleosome-resolution chromosome walks in human cells

    by Jan Soroczynski, Lauren Anderson Westcott, Wu Zuo, Arnold Ou, Hera Canaj, James Hickling, Joanna L Yeung, Hide A Konishi, Ellie B Campbell, Conor Whelan, et al.

    Chromosome conformation capture (3C)-derived methods have become an indispensable tool in the study of gene regulation. The three-dimensional contacts probed by 3C methods depend strongly on the properties of the enzyme used to fragment chromatin prior to proximity-driven ligation. Micrococcal nuclease (MNase), used in Micro-C, increases resolution at the expense of low ligation efficiency and the need for extensive enzyme titration. To overcome these limitations, we engineered a highly active, TEV protease-activatable caspase-activated DNase (CAD) to enable an efficient, low-sequence-bias, and high-resolution proximity ligation assay we call CAD-C. CAD-C was successful on the first attempt for each human cell line tested and the resulting datasets capture loops, TADs, compartments, and stripes similarly to Micro-C. However, compared to Micro-C and Hi-C, CAD-C shows enhanced sensitivity for promoter-enhancer loops. Leveraging the ligation-competent DNA ends produced by CAD cleavage, we show that CAD-C is compatible with a highly streamlined, repair-free protocol and produces multi-step CADwalks, consecutive ligations between nucleosomal or sub-nucleosomal fragments. With these walks, we probe local chromatin fiber folding contacts, nucleosomal and sub-nucleosomal footprints, and long-range nuclear organization regimes in human cell lines. CAD-C is an efficient, robust chromatin structure assay that can span sub-nucleosomal to chromosomal length scales in a single experiment.


  • Open Access

    CDK4/6 inhibition induces a DNA damage-independent senescence-associated secretory phenotype driven by delayed activation of NF-κB

    by Joanna Lan-Hing Yeung, Justin Rendleman, Lauren Anderson Westcott, Arnold Ou, Matthew Pressler, Nicole Pagane, Irene Duba, Ria Hosuru, Bat-Ider Tumenbayar, Viviana I. Risca

    Cellular senescence consists of regulated cell phenotypes associated with permanent exit from the cell cycle in response to stressors such as genomic instability. The consequences of senescence go beyond individual cells due to the senescence associated secretory phenotype (SASP), which can induce inflammation in neighboring cells. Some cancers respond to CDK4/6 inhibitors (CDK4/6i)—a family of targeted therapies that inhibit proliferation—with a senescence-like phenotype in the absence of DNA damage. We asked how the SASP and the transcriptional regulatory profile triggered by CDK4/6i-driven arrest compares to the canonical NF-κB-regulated SASP triggered by DNA damage. We profiled the temporal dynamics of transcriptional regulation in response to the CDK4/6i, palbociclib, and the DNA damaging agent, doxorubicin. We found that, although upregulation of NF-κB driven-SASP genes is shared across both drugs, it is delayed in CDK4/6i. This coincides with slower enhancer activation and epigenetic changes. Interestingly, ATM/ATR inhibition does not affect CDK4/6i-induced NF-κB nuclear localization, pointing to an alternative mechanism driving NF-κB activity in the absence of DNA damage. Inhibiting NF-κB suppresses the expression of shared SASP genes without reversing stable arrest. This points to SASP manipulation as a potential therapeutic strategy, and resolves an ongoing controversy about the nature of cell cycle arrest-driven SASP.

  • The role of G-Quadruplex DNA in Paraspeckle formation in cancer

    by Uditi Bhatt, Amy L. Kretzmann, Aurore Guédin, Arnold Ou, Simon Kobelke, Charles S. Bond, Cameron W. Evans, Laurence H. Hurley, Jean-Louis Mergny, K. Swaminathan Iyer, et al.


  • Open Access

    High resolution crystal structure of a KRAS promoter G-quadruplex reveals a dimer with extensive poly-A π-stacking interactions for small-molecule recognition

    by Arnold Ou, Jason W Schmidberger, Katie A Wilson, Cameron W Evans, Jessica A Hargreaves, Melanie Grigg, Megan L O’mara, K Swaminathan Iyer, Charles S Bond, Nicole M Smith

    Aberrant KRAS signaling is a driver of many cancers and yet remains an elusive target for drug therapy. The nuclease hypersensitive element of the KRAS promoter has been reported to form secondary DNA structures called G-quadruplexes (G4s) which may play important roles in regulating KRAS expression, and has spurred interest in structural elucidation studies of the KRAS G-quadruplexes. Here, we report the first high-resolution crystal structure (1.6 Å) of a KRAS G-quadruplex as a 5′-head-to-head dimer with extensive poly-A π-stacking interactions observed across the dimer. Molecular dynamics simulations confirmed that the poly-A π-stacking interactions are also maintained in the G4 monomers. Docking and molecular dynamics simulations with two G4 ligands that display high stabilization of the KRAS G4 indicated the poly-A loop was a binding site for these ligands in addition to the 5′-G-tetrad. Given sequence and structural variability in the loop regions provide the opportunity for small-molecule targeting of specific G4s, we envisage this high-resolution crystal structure for the KRAS G-quadruplex will aid in the rational design of ligands to selectively target KRAS.


  • Multicarbazole scaffolds for selective G-quadruplex binding

    by Arnold Ou, Aurore Guédin, Brian W. Skelton, Samir Amrane, Cameron W. Evans, Marck Norret, K. Swaminathan Iyer, Jean-Louis Mergny, Nicole M. Smith

    Herein we report a new class of G-quadruplex stabilising ligands, multicarbazoles, which display high G-quadruplex DNA selectivity in the presence of 250 times excess duplex DNA. We report the synthesis of these compounds in moderate to high yields. Ligands in the series with optimal G-quadruplex selectivity contain an N-propylamino chain length where the amino functionalities are either pyrrolidine or piperidine.


  • New, potentially chelating NHC ligands; synthesis, complexation studies, and preliminary catalytic evaluation

    by Arnold Ou, Linglin Wu, Alvaro Salvador, Gellert Sipos, Guangzhen Zhao, Brian W. Skelton, Alexandre N. Sobolev, Reto Dorta

    Two new N-heterocyclic carbene (NHC) ligands bearing 2-morpholino and 2-piperidinyl naphthyl wingtips were synthesised (2-SIMorNap and 2-SIPipNap). Nuclear magnetic resonance studies, in conjunction with crystal structures and derivatisation of the NHC salts using a chiral counteranion, revealed that the ligand wingtips are oriented anti with respect to each other. From the free carbene, palladium, ruthenium and iridium complexes were prepared. NHC–iridium dicarbonyl complexes were made in order to extract the TEP values for these ligands. The study showed that these NHC ligands are more electron-donating than normal, aryl-substituted NHCs. The palladium complexes were tested in representative Suzuki–Miyaura cross-coupling reactions and compared to the state of the art systems. Ruthenium-catalysed ring-closing metathesis with these ligands was also performed. It was found that Grubbs’ 2nd generation catalyst incorporating 2-SIPipNap did not initiate at room temperature and required heating for RCM to occur.


  • ChemInform Abstract: A Chiral Disulfoxide Ligand for the Efficient Rhodium‐Catalyzed 1,2‐Addition of Arylboroxines to N‐Tosylarylimines.

    by Guang‐Zhen Zhao, Gellert Sipos, Alvaro Salvador, Arnold Ou, Pengchao Gao, Brian W. Skelton, Reto Dorta

    Affording enantiomerically pure diarylmethylamines

  • ChemInform Abstract: Unusual NHC‐Iridium(I) Complexes and Their Use in the Intramolecular Hydroamination of Unactivated Aminoalkenes.

    by Gellert Sipos, Arnold Ou, Brian W. Skelton, Laura Falivene, Luigi Cavallo, Reto Dorta

  • ChemInform Abstract: Monodentate Chiral N-Heterocyclic Carbene—Palladium-Catalyzed Asymmetric Suzuki—Miyaura and Kumada Coupling.

    by Linglin Wu, Alvaro Salvador, Arnold Ou, Ming Wen Shi, Brian W. Skelton, Reto Dorta

    A novel complex PNC is tested in the title reactions to produce the chiral biaryls with low to moderate e.e′s.